Standards Desk · recorded August 2026
Seller record · telehealth service · hims.com · forhers.com
Hims & Hers
One company operates two consumer storefronts. The weight loss range is brand GLP-1 drugs, and the terms name six filling pharmacies.
Passes 7 of 8 criteria. Recorded against Standard v1.1, August 2026.
Operating entity Hims & Hers Health, Inc. One entity operates 2 storefronts, recorded here as one entry: hims.com, forhers.com.
Dispositions at a glance
Evidence, criterion by criterion
What was read, where, and on what date, for each disposition in the table above.
S1PASSPrescription products require an online consultation with a healthcare provider who determines whether a prescription is appropriate.Source: hims.com/sex/hard-mints · read August 2026. S2PASSThe order path was walked from the weight loss page and stopped at the first intake question, which asks the buyer's weight loss goal.Source: hims.com/g/i/mm-wm/your-goal · read August 2026. S3PASSSix pharmacies are named in the terms: Apostrophe Pharmacy, XeCare, EHT Pharmacy doing business as Curexa, CD Pharmacy doing business as Red Rock Pharmacy, AnazaoHealth Corporation, and Strive Specialties.Source: hims.com/terms-and-conditions · read August 2026. S4PASSThe featured products include compounded products which have not been approved by the FDA, printed in the body of the product page.Source: hims.com/sex/hard-mints · read August 2026. S5FAILNo certificate, lot report or test document appears on the compounded product page, in the terms, or among the 2,434 addresses the sitemap lists.Source: hims.com/sitemap.xml · read August 2026. S6PASSHims & Hers Health, Inc. at 2269 Chestnut Street, #523, San Francisco, CA 94123, printed in the terms and matching the address on both warning letters.Source: hims.com/terms-and-conditions · read August 2026. S7PASSWegovy Pill from 149 dollars per month, Wegovy Pen from 199 dollars per month and Zepbound Vial from 299 dollars per month, each marked membership required.Source: hims.com/weight-loss · read August 2026. S8PASSFDA warning letter 716567 and FDA warning letter 716825, both September 2025, name Hims & Hers Health, Inc. doing business as Hims and as Hers at 2269 Chestnut St., #523, San Francisco, California, the address its own terms print. Each alleges that claims for its compounded semaglutide products, among them the same active ingredient as Ozempic and Wegovy, are false or misleading. No close-out letter appears in the index. No FDA action has halted the business, and the company continues to operate.Source: fda.gov, letters 716567 and 716825 · read August 2026. Products shown on the seller's own pages at the recorded date: brand Wegovy, brand Zepbound, brand Ozempic, compounded sexual health medications, sildenafil, finasteride and minoxidil, escitalopram.
Dispositions recorded against Standard v1.1, August 2026. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.